Clay Isbell

Clay Isbell is a fitness enthusiast currently with The Runners Forum since November 2023 and is on sabbatical in personal development since August 2023. Previously, Clay managed a communications program for a $2.4 billion therapy at Parexel as the Manager of Scientific Services from November 2021 to July 2023. Clay also served as Senior Scientific Director at Envision Pharma Group, where market analysis was led for a blockbuster immuno-therapy valued at $5.6 billion annually from April 2018 to October 2021, and at The Lockwood Group, where the development of an engagement plan for a novel therapy valued at $450 million annually was overseen from October 2016 to March 2018. Earlier roles included Principal Medical Writer at Envision Pharma Group, contributing to market insights and advisory boards from March 2011 to September 2016, and additional experience at Communications and Research from April 1991 to February 2011. Clay holds both a Master of Arts and a Bachelor of Arts in English from the University of Alabama at Birmingham, with a minor in Chemistry.